Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INTENSIFY BD: Intensified Pharmacological Treatment for Bipolar Depression
NCT05973786Phase 3Recruiting
- Start
- Feb 2025
- Primary completion
- Jun 2028
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 3 trial of escitalopram, sertraline, venlafaxine, bupropion in bipolar disorder (BD). Started Feb 2025; status: recruiting.
02
Drugs
escitalopramsertralinevenlafaxinebupropion
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT05973786.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05973786.